Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	292.09	415.52	546.09	246.55	398.7
Cash & Short-Term Investments	292.09	415.52	546.09	246.55	398.7
Cash Growth	-29.70%	-23.91%	121.50%	-38.16%	12.55%
Accounts Receivable	101.34	117.29	98.13	94.5	52.04
Other Receivables	17.48	23.74	20.25	9.76	11.88
Receivables	118.82	141.04	118.37	104.26	63.91
Inventory	248.46	227.41	141.6	106.57	77.59
Prepaid Expenses	28.85	29.11	20.34	10.14	7.34
Total Current Assets	688.21	813.08	826.41	467.51	547.53
Property, Plant & Equipment	213.88	149.04	97.55	47.58	26.3
Long-Term Investments	0.63	0.9	0.58	0.41	1.16
Goodwill	610.06	682.48	591.39	625.32	460.23
Other Intangible Assets	39.61	48.7	30.46	8.49	8.66
Long-Term Deferred Tax Assets	21.04	32.45	50.71	39.27	42.17
Long-Term Deferred Charges	800.68	676.09	598.51	544.51	456.55
Total Assets	2,374	2,403	2,196	1,733	1,543
Accounts Payable	31.5	39.45	36.05	38.47	21.45
Accrued Expenses	47.54	85.08	68.94	52.65	46.96
Current Portion of Leases	11.56	10.92	10.27	5.55	4.2
Current Income Taxes Payable	6.62	11.93	11.87	1.28	0.3
Current Unearned Revenue	11.62	13.47	3.69	3.17	3.01
Other Current Liabilities	10.53	16.67	3.66	33.77	28.6
Total Current Liabilities	119.38	177.51	134.49	134.9	104.52
Long-Term Leases	113.17	23.13	21.17	4.46	1.52
Long-Term Deferred Tax Liabilities	26.24	27.85	29.29	25.77	25.08
Other Long-Term Liabilities	1.87	17.48	65.62	137.83	126.02
Total Liabilities	260.65	245.97	250.57	302.95	257.15
Common Stock	0.82	0.81	0.81	0.76	0.75
Additional Paid-In Capital	1,785	1,772	1,764	1,314	1,253
Retained Earnings	316.91	291.76	119.57	27.75	9.28
Comprehensive Income & Other	10.65	92.19	60.89	87.78	22.09
Shareholders' Equity	2,113	2,157	1,945	1,430	1,285
Total Liabilities & Equity	2,374	2,403	2,196	1,733	1,543
Total Debt	124.72	34.04	31.44	10.01	5.72
Net Cash (Debt)	167.37	381.48	514.65	236.54	392.98
Net Cash Growth	-56.13%	-25.88%	117.58%	-39.81%	13.24%
Net Cash Per Share	5.30	12.05	17.19	8.01	13.58
Filing Date Shares Outstanding	31.5	31.5	31.5	29.83	29.5
Total Common Shares Outstanding	31.5	31.5	31.5	29.83	29.5
Working Capital	568.83	635.57	691.92	332.61	443.01
Book Value Per Share	67.10	68.47	61.75	47.94	43.58
Tangible Book Value	1,464	1,426	1,323	796.33	816.56
Tangible Book Value Per Share	46.47	45.26	42.01	26.69	27.68
Machinery	307.41	217.57	153.61	98.52	68.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.